Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2014
11/06/2014US20140328908 Controlled-release formulation
11/06/2014US20140328907 Entrapment of bioactives in sol-gel alumina materials
11/06/2014US20140328905 Methods and compositions for x-ray induced release from ph sensitive liposomes
11/06/2014US20140328904 Gla monotherapy for use in cancer treatment
11/06/2014US20140328902 Antimicrobials and methods of use thereof for wound healing
11/06/2014US20140328896 Compositions and methods for modifying gastrointestinal flora
11/06/2014US20140328893 Nutlin compounds for use in the treatment of pulmonary hypertension
11/06/2014US20140328892 Use of alfimeprase in the treatment of thrombosis
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/06/2014US20140328843 Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof
11/06/2014US20140328840 Marker and target for responsiveness and resistance to cancer agents
11/06/2014US20140328839 Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma
11/06/2014US20140328836 HER2/neu-Specific Antibodies and Methods of Using Same
11/06/2014US20140328829 Agr2 blocking antibody and use thereof
11/06/2014US20140328827 Methods for Fucoidan Purification from Seaweed Extracts
11/06/2014US20140328823 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
11/06/2014US20140328813 Combination Bacteriolytic Therapy for the Treatment of Tumors
11/06/2014US20140328797 Human rhinovirus (hrv) antibodies
11/06/2014US20140328796 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/06/2014US20140328795 Virucidal small molecule and uses thereof
11/06/2014US20140328793 Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
11/06/2014US20140328792 Methods and compositions for treating and preventing viral infections
11/06/2014US20140328778 Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis
11/06/2014US20140328770 Topical tetracycline compositions
11/06/2014US20140328750 Antibodies Reactive with B7-H3 and Uses Thereof
11/06/2014US20140326759 Medicinal aerosols and methods of delivery thereof
11/04/2014US8877899 Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
11/04/2014US8877820 Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
11/04/2014US8877801 Compounds and compositions as selective estrogen receptor degraders
11/04/2014US8877796 Spiro-oxindole MDM2 antagonists
11/04/2014US8877793 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
11/04/2014US8877786 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
11/04/2014US8877772 Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors
11/04/2014US8877771 Treatment of solid tumors with rapamycin derivatives
11/04/2014US8877768 Method and composition for treating alzheimer-type dementia
11/04/2014US8877763 Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
11/04/2014US8877759 Aminopyrazines as ATR kinase inhibitors
11/04/2014US8877758 Combinations of medicaments, containing PDE4-inhibitors and EP4-receptor-antagonists
11/04/2014US8877755 Dopamine-agonist combination therapy for improving sleep quality
11/04/2014US8877753 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
11/04/2014US8877743 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
11/04/2014US8877733 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
11/04/2014US8877732 Combination, kit and method of reducing intraocular pressure
11/04/2014US8877731 Azido nucleosides and nucleotide analogs
11/04/2014US8877708 Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
11/04/2014US8877494 Human corneal epithelial cell line PTA-120527
11/04/2014US8877443 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/04/2014US8877260 Use of acacia extracts and their compounds on inhibition of xanthine oxidase
11/04/2014US8877255 Microporous zirconium silicate for the treatment of hyperkalemia
11/04/2014US8877240 Tablet binding compositions
11/04/2014US8877228 Treatment of ophthalmic conditions
11/04/2014US8877209 Recombinant influenza vectors with tandem transcription units
11/04/2014US8877208 Multivalent nanoemulsion vaccines
11/04/2014US8877205 Yeast-based therapeutic for chronic hepatitis B infection
11/04/2014US8877200 HA binding agents
11/04/2014US8877196 Methods of altering bone growth by administration of sost or wise antagonist or agonist
11/04/2014US8877188 Detection and treatment of non-dermal fibrosis
11/04/2014US8877178 Methods of use of probiotic bifidobacteria for companion animals
11/04/2014US8877165 Solid preparation for oral application
11/04/2014US8877161 GM1-like peptides and uses thereof
10/2014
10/30/2014US20140324157 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
10/30/2014US20140323693 Antibodies To Non-Functional P2X7 Receptor
10/30/2014US20140323576 Method for treating glioblastomas and other tumors
10/30/2014US20140323568 Oligo-benzamide compounds and their use in treating cancers
10/30/2014US20140323553 Methods and Compositions Related to MiR-21 & MiR-29a, Exosome Inhibition, and Cancer Metastasis
10/30/2014US20140323536 TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
10/30/2014US20140323533 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
10/30/2014US20140323513 Chemotherapeutic Compositions and Methods for Treating Human Gliomas
10/30/2014US20140323511 Chemotherapeutic for inducing an msh2 dependent apoptotic pathway
10/30/2014US20140323507 Mycophenolic acid analogues as anti-tumor chemosensitizing agents
10/30/2014US20140323505 Oral rinse composition and method to deliver energy supplements
10/30/2014US20140323503 Inhibitors of phospodiesterases 11 (pde11) and methods of use to elevate cortisol production
10/30/2014US20140323500 Nadph oxidase 4 inhibitors and use thereof
10/30/2014US20140323487 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323484 Pharmaceutically Active Pyrazine Derivatives
10/30/2014US20140323481 3-cyanoaryl-1h-pyrrolo[2,3-b]pyridine derivatives
10/30/2014US20140323478 Serine/threonine kinase inhibitors
10/30/2014US20140323477 Serine/threonine kinase inhibitors
10/30/2014US20140323465 Hcv protease inhibitors and uses thereof
10/30/2014US20140323447 Heteroaromatic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
10/30/2014US20140323446 Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients
10/30/2014US20140323442 Small Molecule Modulators of pRb Inactivation
10/30/2014US20140323439 Therapies for hematologic malignancies
10/30/2014US20140323438 Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis
10/30/2014US20140323425 Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment
10/30/2014US20140323420 Reducing transmission of sexually transmitted infections
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/30/2014US20140323409 Apotransferrin for the treatment of brain stroke
10/30/2014US20140323392 Methods and compositions related to inhibition of viral entry
10/30/2014US20140322407 Medium chain peroxycarboxylic acid compositions
10/30/2014US20140322363 Treatment of withdrawal symptoms to aid in nicotine use cessation with passiflora incarnata
10/30/2014US20140322361 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof
10/30/2014US20140322355 Heterocyclic modulators of lipid synthesis
10/30/2014US20140322345 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/30/2014US20140322331 Calcipotriol monohydrate nanocrystals
10/30/2014US20140322315 Cysteamine and/or cystamine for treating ischemic injury
10/30/2014US20140322312 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
10/30/2014US20140322307 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 1151